Track topics on Twitter Track topics that are important to you
Yesterday, Federal District Court Judge R. David Proctor issued a Memorandum Opinion and Order granting in part Provider Plaintiffs’ Motion for Partial Summary Judgment on the A...
"Since joining Oakworth, Bill has embraced and consistently lived our core values," said Forest Whatley, Managing Director, Markets and Risk Management. "Adding Bill to Read more...
Vitruvias Therapeutics Inc., a private generic pharmaceutical company with a focus on sterile injectables, announced today the completion of a $11.5 million Series A preferred fin...
Vitruvias is an emerging specialty pharmaceutical company which develops, manufactures, and markets generic prescription products for the U.S. and Canadian markets. Founded in 201...
We have published hundreds of Whatley Kallas LLP news stories on BioPortfolio along with dozens of Whatley Kallas LLP Clinical Trials and PubMed Articles about Whatley Kallas LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Whatley Kallas LLP Companies in our database. You can also find out about relevant Whatley Kallas LLP Drugs and Medications on this site too.